Clinical Trial Update: Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the antifibrotic activity of Fuzheng Huayu in patients with chronic hepatitis C and hepatic fibrosis; study completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Fibrosis
• Hepatitis C

Drugs mentioned

• Fuzheng Huayu

Snippet

Sponsor: Tarek Hassanein | Conditions: Chronic Hepatitis C Infection | Phase 2 | Status: COMPLETED | Results posted: 2014-06-18